Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Zeng, L.
Right arrow Articles by Danesh, F. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Zeng, L.
Right arrow Articles by Danesh, F. R.
J Am Soc Nephrol 15:1711-1720, 2004
© 2004 American Society of Nephrology


BASIC SCIENCE

Simvastatin Modulates Angiotensin II Signaling Pathway by Preventing Rac1-Mediated Upregulation of p27

Lixia Zeng*, Hanshi Xu*, Teng-Leong Chew{dagger}, Rex Chisholm{dagger}, Mehran M. Sadeghi{ddagger}, Yashpal S. Kanwar§ and Farhad R. Danesh*

*Division of Nephrology/Hypertension, {dagger}Department of Cell and Molecular Biology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois; {ddagger}Division of Cardiology, Yale University School of Medicine, New Haven, Connecticut; and §Department of Pathology, Northwestern University, Chicago, Illinois

Correspondence to Dr. Farhad R. Danesh, Division of Nephrology/Hypertension, Feinberg School of Medicine, Northwestern University Medical School, Morton Building 2-615, 303 East Chicago Avenue, Chicago, IL 60611. Phone: 312-503-4753; Fax: 312-503-0622; E-mail: f-rahimi{at}northwestern.edu

ABSTRACT. Recent experimental observations have suggested that statins may exert modulatory effects on a number of pathobiological processes beyond their cholesterol-lowering properties. Some of the pleiotropic effects of statins seem to be mediated by their ability to block the synthesis of isoprenoid intermediates, which serve as important lipid attachments required for the proper function and activation of the small GTP-binding proteins. The current study explored the modulatory effects of simvastatin (SMV) on the angiotensin II (Ang II)-induced Rac1-mediated, upregulation of cyclin-dependent kinase inhibitor p27. Ang II (100 nM) stimulation of rat mesangial cells induced a significant increase in p27 protein expression. Co-treatment of cells with SMV (1 µM) inhibited Ang II–induced upregulation of p27 protein. Addition of mevalonate (200 µM) or geranylgeranyl pyrophosphate (5 µM) reversed the inhibitory effect of SMV on p27 protein expression, suggesting that the effect of SMV is geranylgeranyl dependent. This study also provides evidence for a sequential link between Ang II stimulation and downstream activation of Rac1, intracellular H2O2 production, and Akt kinase leading to upregulation of p27 protein in mesangial cells. It was also shown that SMV, by inhibiting Rac1 activity, reversed Ang II–induced increase in intracellular H2O2 production, Akt activation, and p27 protein expression. The data presented in this study not only elucidate Ang II–mediated signaling cascade in mesangial cells but also demonstrate for the first time the modulatory effects of SMV on Ang II–induced signaling pathway at the cell cycle level.




This article has been cited by other articles:


Home page
DiabetesHome page
V. Kolavennu, L. Zeng, H. Peng, Y. Wang, and F. R. Danesh
Targeting of RhoA/ROCK Signaling Ameliorates Progression of Diabetic Nephropathy Independent of Glucose Control
Diabetes, March 1, 2008; 57(3): 714 - 723.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
Y. S. Kanwar, J. Wada, L. Sun, P. Xie, E. I. Wallner, S. Chen, S. Chugh, and F. R. Danesh
Diabetic Nephropathy: Mechanisms of Renal Disease Progression
Experimental Biology and Medicine, January 1, 2008; 233(1): 4 - 11.
[Abstract] [Full Text] [PDF]


Home page
CJASNHome page
M. Franciosi, F. Pellegrini, M. Sacco, G. De Berardis, M. C.E. Rossi, G. F.M. Strippoli, M. Belfiglio, G. Tognoni, M. Valentini, A. Nicolucci, et al.
Identifying Patients at Risk for Microalbuminuria via Interaction of the Components of the Metabolic Syndrome: A Cross-Sectional Analytic Study
Clin. J. Am. Soc. Nephrol., September 1, 2007; 2(5): 984 - 991.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
I. H. Zucker
Novel Mechanisms of Sympathetic Regulation in Chronic Heart Failure
Hypertension, December 1, 2006; 48(6): 1005 - 1011.
[Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
H. Xu, L. Zeng, H. Peng, S. Chen, J. Jones, T.-L. Chew, M. M. Sadeghi, Y. S. Kanwar, and F. R. Danesh
HMG-CoA reductase inhibitor simvastatin mitigates VEGF-induced "inside-out" signaling to extracellular matrix by preventing RhoA activation
Am J Physiol Renal Physiol, November 1, 2006; 291(5): F995 - F1004.
[Abstract] [Full Text] [PDF]


Home page
Physiol. GenomicsHome page
S. D. Hingtgen, X. Tian, J. Yang, S. M. Dunlay, A. S. Peek, Y. Wu, R. V. Sharma, J. F. Engelhardt, and R. L. Davisson
Nox2-containing NADPH oxidase and Akt activation play a key role in angiotensin II-induced cardiomyocyte hypertrophy
Physiol Genomics, September 14, 2006; 26(3): 180 - 191.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. K. Banes-Berceli, S. Shaw, G. Ma, M. Brands, D. C. Eaton, D. M. Stern, D. Fulton, R. W. Caldwell, and M. B. Marrero
Effect of simvastatin on high glucose- and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells
Am J Physiol Renal Physiol, July 1, 2006; 291(1): F116 - F121.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
N.-H. Kim, H. Rincon-Choles, B. Bhandari, G. G. Choudhury, H. E. Abboud, and Y. Gorin
Redox dependence of glomerular epithelial cell hypertrophy in response to glucose
Am J Physiol Renal Physiol, March 1, 2006; 290(3): F741 - F751.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
S. Chen, J. S. Lee, M. C. Iglesias-de la Cruz, A. Wang, A. Izquierdo-Lahuerta, N. K. Gandhi, F. R. Danesh, G. Wolf, and F. N. Ziyadeh
Angiotensin II stimulates {alpha}3(IV) collagen production in mouse podocytes via TGF-{beta} and VEGF signalling: implications for diabetic glomerulopathy
Nephrol. Dial. Transplant., July 1, 2005; 20(7): 1320 - 1328.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
H. Nishimatsu, E. Suzuki, H. Satonaka, R. Takeda, M. Omata, T. Fujita, R. Nagai, T. Kitamura, and Y. Hirata
Endothelial dysfunction and hypercontractility of vascular myocytes are ameliorated by fluvastatin in obese Zucker rats
Am J Physiol Heart Circ Physiol, April 1, 2005; 288(4): H1770 - H1776.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
D. Feliers, S. Duraisamy, J. L. Barnes, G. Ghosh-Choudhury, and B. S. Kasinath
Translational regulation of vascular endothelial growth factor expression in renal epithelial cells by angiotensin II
Am J Physiol Renal Physiol, March 1, 2005; 288(3): F521 - F529.
[Abstract] [Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP